Fullerton Fund Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.7M | Sell |
16,521
-3,326
| -17% | -$1.35M | 0.27% | 39 |
|
|
2025
Q1 | $9.88M | Sell |
19,847
-5,203
| -21% | -$2.59M | 0.63% | 36 |
|
|
2024
Q4 | $13M | Sell |
25,050
-51,777
| -67% | -$26.9M | 0.46% | 37 |
|
|
2024
Q3 | $47.5M | Buy |
76,827
+62,704
| +444% | +$38.8M | 2% | 16 |
|
|
2024
Q2 | $7.81M | Sell |
14,123
-20,069
| -59% | -$11.1M | 0.35% | 38 |
|
|
2024
Q1 | $19.9M | Sell |
34,192
-7,695
| -18% | -$4.47M | 0.94% | 24 |
|
|
2023
Q4 | $22.2M | Sell |
41,887
-12,882
| -24% | -$6.84M | 1.29% | 21 |
|
|
2023
Q3 | $27.7M | Buy |
54,769
+3,961
| +8% | +$2M | 1.94% | 17 |
|
|
2023
Q2 | $26.5M | Buy |
50,808
+3,529
| +7% | +$1.84M | 1.85% | 18 |
|
|
2023
Q1 | $27.3M | Buy |
47,279
+1,817
| +4% | +$1.05M | 2.07% | 16 |
|
|
2022
Q4 | $25M | Sell |
45,462
-35,563
| -44% | -$19.6M | 1.86% | 22 |
|
|
2022
Q3 | $41.1M | Buy |
81,025
+11,151
| +16% | +$5.66M | 3.06% | 15 |
|
|
2022
Q2 | $38M | Sell |
69,874
-12,319
| -15% | -$6.69M | 2.52% | 17 |
|
|
2022
Q1 | $48.5M | Sell |
82,193
-40,618
| -33% | -$24M | 2.57% | 14 |
|
|
2021
Q4 | $81.9M | Buy |
122,811
+26,859
| +28% | +$17.9M | 4.11% | 7 |
|
|
2021
Q3 | $54.8M | Buy |
+95,952
| New | +$54.8M | 3.33% | 8 |
|
|
2021
Q1 | – | Sell |
-33,802
| Closed | -$15.7M | – | 90 |
|
|
2020
Q4 | $15.7M | Buy |
33,802
+16,495
| +95% | +$7.68M | 1.16% | 32 |
|
|
2020
Q3 | $7.64M | Buy |
17,307
+5,206
| +43% | +$2.3M | 1.02% | 25 |
|
|
2020
Q2 | $4.39M | Hold |
12,101
| – | – | 0.8% | 26 |
|
|
2020
Q1 | $3.43M | Buy |
12,101
+4,319
| +55% | +$1.22M | 0.65% | 18 |
|
|
2019
Q4 | $2.53M | Buy |
+7,782
| New | +$2.53M | 0.53% | 25 |
|